ENZO BIOCHEM INC (ENZ)
US2941001024 - Common Stock
| MRQ (2024-1-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | 2020 (2020-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 60.24M | 82.37M | 21.60M | 13.52M | 47.90M | |||
| Marketable Securities | N/A | N/A | 0.00 | 29.98M | N/A | |||
| Receivables | 5.12M | 4.81M | 4.76M | 10.20M | 9.10M | |||
| Inventories | 7.80M | 7.94M | 9.52M | 12.65M | 7.80M | |||
| Other Current Assets | 7.76M | 3.34M | 6.94M | 4.23M | 4.00M | |||
| Total Current Assets | 80.92M | 98.46M | 42.82M | 70.58M | 68.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 16.02M | 16.71M | 16.02M | 33.60M | 34.40M | |||
| Goodwill | N/A | N/A | 7.45M | 7.45M | 7.50M | |||
| Intangibles | N/A | N/A | 0.00 | 244.00K | 500.00K | |||
| Other Non-Current Assets | 2.13M | 6.71M | 16.77M | 1.81M | 1.40M | |||
| Total Non-Current Assets | 18.16M | 23.42M | 32.79M | 43.11M | 43.70M | |||
| TOTAL ASSETS | 99.08M | 121.88M | 75.61M | 113.69M | 112.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 3.23M | 2.51M | 0.00 | 0.00 | 7.00M | |||
| Current Portion Of LT Debt. | 75.00K | 75.00K | 229.00K | 233.00K | 300.00K | |||
| Accrued Expenses | 8.39M | 12.72M | 9.07M | 15.04M | 14.40M | |||
| Accounts Payable | 1.32M | 3.58M | 3.71M | 8.12M | 8.50M | |||
| Other Current Liabilities | 12.28M | 21.10M | 0.00 | 2.67M | 2.50M | |||
| Total Current Liabilities | 25.28M | 39.99M | 13.02M | 26.08M | 32.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 234.00K | 269.00K | 4.08M | 4.47M | 4.60M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 2.79M | 3.16M | 4.05M | 14.56M | 16.70M | |||
| Total Non-Current Liabilities | 3.02M | 3.43M | 8.13M | 19.03M | 21.40M | |||
| TOTAL LIABILITIES | 28.30M | 43.42M | 21.15M | 45.10M | 54.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -278.03M | -268.35M | -288.64M | -270.38M | -278.30M | |||
| Additional Paid In Capital | 346.25M | 344.44M | 339.46M | 337.13M | 334.50M | |||
| Common Shares | 504.00K | 499.00K | 487.00K | 485.00K | 500.00K | |||
| Other Shareholders' Equity | 2.05M | 1.88M | 3.15M | 1.35M | 1.70M | |||
| Shares Outstanding | 50.49M | 50.00M | 48.72M | 48.47M | 47.90M | |||
| Tangible Book Value per Share | 1.40 | 1.57 | 1.12 | 1.26 | 1.05 | |||
| Total Shareholders' Equity | 70.78M | 78.46M | 54.46M | 68.59M | 58.40M | |||
| TOTAL LIABILITIES AND EQUITY | 99.08M | 121.88M | 75.61M | 113.69M | 112.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.05 | 0.04 | 0.07 | 0.07 | 0.20 | |||
| Current Ratio | 3.20 | 2.46 | 3.29 | 2.71 | 2.10 | |||
| Return On Assets (ROA) | -4.62% | 16.65% | -24.15% | 6.93% | -25.33% | |||
| Return On Equity (ROE) | -6.47% | 25.86% | -33.53% | 11.48% | -48.80% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 4.89% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 9.71% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | 11.76% | N/A | |||
All data in USD